Prévisions du marché de l’immunohistochimie au Moyen-Orient et en Afrique jusqu’en 2028 – Impact du COVID-19 et analyse régionale par application (diagnostics et tests de médicaments), produit (anticorps, équipements, réactifs et kits) et utilisateur final (hôpitaux et laboratoires de diagnostic, instituts de recherche, et d\'autres)

Présentation du marché

Les Émirats arabes unis (EAU), l\'Arabie saoudite et l\'Afrique du Sud sont les trois principaux pays de la MEA. L\'Arabie saoudite était le plus grand marché d\'immunohistochimie dans cette région en 2021. L\'Arabie saoudite est l\'un des pays à la croissance la plus rapide au Moyen-Orient et en Afrique, avec une importante population souffrant de cancer qui alimente sa croissance. De plus, l’Arabie saoudite (Arabie Saoudite) a adopté la Vision saoudienne 2030 qui donne la priorité à la prévention et à la promotion d’un nouveau modèle de soins pour les maladies non transmissibles (MNT). De plus, l’incidence et la prévalence estimées du cancer augmenteront deux fois d’ici 2030 en Arabie Saoudite. Selon l\'OMS en 2018, environ 24 485 nouveaux cas de cancer ont été enregistrés dans le pays. Parmi eux, les cas de cancer du sein étaient d\'environ 3 629 ; les cas de cancer colorectum étaient de 3 564. La présence de laboratoires proposant des procédures de diagnostic devrait également alimenter la croissance du marché. Les laboratoires médicaux Al Borg, basés en Arabie Saoudite, par exemple, proposent une large gamme de tests de laboratoire de routine, spécialisés et sous-spécialisés. Elle offre d\'excellents services de médecine de laboratoire de pointe dans tout le Moyen-Orient. Le plan stratégique de l\'Autorité saoudienne des produits alimentaires et pharmaceutiques (2018-2022) a récemment été proposé par le gouvernement comme troisième plan stratégique annuel. Le projet intègre la vision et les priorités stratégiques développées par les régulateurs des médicaments, des aliments et des dispositifs médicaux. Ils ont également l\'intention de créer un laboratoire central d\'essais à Riyad à des fins de recherche. En outre, le gouvernement prévoit de consacrer près de 13,3 milliards de dollars américains (50 milliards de riyals) d\'ici 2020 à une initiative visant à promouvoir le divertissement, la santé, le sport et l\'éducation. Par conséquent, l\'augmentation de meilleures installations pour la santé et l\'éducation est susceptible de créer de bonnes opportunités pour le marché de l\'immunohistochimie.

En cas de COVID-19, la MEA est fortement touchée, en particulier l\'Afrique du Sud. Les incertitudes économiques et les conflits en cours aggravent la situation dans la région. Par exemple, des pays comme la Syrie, la Libye et le Yémen sont confrontés à des conflits violents et ne peuvent pas mettre en œuvre de mesures de santé publique robustes. L’Iran était plongé dans une profonde récession économique en raison des sanctions américaines. En outre, la principale source de stabilisation économique dans les pays du Moyen-Orient est la production et l’exportation de pétrole. Cependant, la récente pandémie provoque des turbulences dans les économies du Moyen-Orient. Une chute soudaine de la demande intérieure et extérieure de biens et de produits, en particulier de pétrole brut, et l\'arrêt de la production en raison d\'une pénurie de main-d\'œuvre, sont des impacts majeurs observés dans la région. La propagation du coronavirus dans la région a imposé de lourdes charges aux professionnels de santé. Les chirurgiens cardiaques étaient surchargés d’opérations cardiaques d’urgence, de gestion des patients atteints de coronavirus et de mise en œuvre de directives de sécurité pour empêcher la propagation du virus. La propagation rapide du virus a eu un impact sur les chirurgies électives. Ces facteurs devraient entraver la croissance du marché de l’immunohistochimie MEA.

Aperçu et dynamique du marché

Le marché de l’immunohistochimie MEA est devrait passer de 88,98 millions de dollars US en 2021 à 136,50 millions de dollars US d’ici 2028 ; on estime qu’elle connaîtra une croissance à un TCAC de 6,3 % entre 2021 et 2028. Ces dernières années, l’industrie de la biotechnologie se développe à une vitesse extraordinairement rapide. Les fabricants sont confrontés aux diverses difficultés des soins de santé grâce aux médicaments les plus récents, à la numérisation progressive, aux formes de thérapie et à un changement continu de la gestion. Selon les statistiques de l\'Organisation mondiale de la santé (OMS), la population augmente de 1,2 % par an, entraînant une augmentation de la population des personnes âgées. L\'OMS révèle également que la proportion de personnes âgées de 65 à 80 ans passera à 28 % en 2030, contre 22 % en 2000. En outre, l\'urbanisation croissante et le nombre croissant de personnes à revenu intermédiaire incitent les fabricants de médicaments à fabriquer des médicaments raisonnables. responsable de stimuler la croissance du marché. Ces formulations sont produites sur le marché après avoir été soumises à des directives réglementaires strictes en matière de sécurité des patients. Recherche et amp; les dépenses de développement par rapport aux méthodes d\'exploration, d\'examen et de production de produits innovants, aux paiements initiaux et aux jalons, à l\'amélioration des produits et à la démonstration de l\'efficacité du produit et de sa conformité réglementaire avant le lancement. Ainsi, les investissements élevés dans la recherche par les investisseurs, les industries biopharmaceutiques et biotechnologiques devraient propulser la croissance du marché de l’immunohistochimie au cours des années de prévision. Les investissements croissants dans les activités de R&D ont ouvert la voie à la croissance de l’industrie dans les années à venir. De nombreux scientifiques, en partenariat avec d\'autres scientifiques, proposent divers produits pour les bioréacteurs. Ces facteurs devraient inciter les industries biotechnologiques et biopharmaceutiques à réaliser des tests efficaces qui devraient stimuler la croissance du marché MEA.

Segments clés du marché

En termes de produit, le segment des anticorps représentait la plus grande part du marché de l\'immunohistochimie MEA en 2020. En termes d\'application, le segment des diagnostics détenait une part de marché plus importante du marché de l\'immunohistochimie MEA en 2020. , le segment des hôpitaux et des laboratoires de diagnostic détenait une part plus importante du marché de l\'immunohistochimie MEA en fonction de l\'utilisateur final en 2020.

Principales sources et sociétés répertoriées

Quelques sources primaires et secondaires majeures mentionnées pour la préparation de ce rapport sur le marché de l’immunohistochimie MEA sont les sites Web des entreprises, les rapports annuels, les rapports financiers, les documents du gouvernement national et les bases de données statistiques, entre autres. Les principales sociétés répertoriées dans le rapport sont Abcam plc ; Agilent Technologies, Inc. ; Bio SB ; LABORATOIRES BIO-RAD INC.; Danaher ; F. HOFFMANN-LA ROCHE LTÉE; MERCK KGaA ; PerkinElmer Inc. ; et THERMO FISHER SCIENTIFIC INC.

Rapport sur les raisons d\'acheter

< ul>

Comprendre le paysage du marché de l\'immunohistochimie MEA et identifier les segments de marché les plus susceptibles de garantir un fort retour

Gardez une longueur d\'avance en comprenant le paysage concurrentiel en constante évolution du marché de l\'immunohistochimie MEA

Planifier efficacement les fusions et acquisitions et les accords de partenariat sur le marché de l\'immunohistochimie MEA en identifiant les segments de marché avec les ventes probables les plus prometteuses

Aide à prendre des décisions commerciales éclairées à partir d\'une analyse perspicace et complète des performances du marché de divers segments du marché de l\'immunohistochimie MEA

Obtenez les prévisions de revenus du marché pour différents segments de 2021 à 2028 dans la région MEA.

Segmentation du marché de l\'immunohistochimie MEA

Marché de l\'immunohistochimie MEA - Par produit

Équipement
- Systèmes de coloration de lames
- Systèmes de microréseaux de tissus
- Traitement des tissus Systèmes
- Scanners de lames
- Autres équipements
Anticorps
- Anticorps primaires
- Anticorps secondaires
Réactifs
- Colorations histologiques
- Réactifs de blocage et de fixation
- Substrats chromogènes
- Réactifs de fixation
- Stabilisants
- Solvants organiques
- Enzymes protéolytiques
- Diluants
Kits

Marché de l\'immunohistochimie MEA - Par application

Diagnostic
- Cancer
- Maladies infectieuses
- Maladies auto-immunes
- Diabète sucré
- Maladies néphrologiques
- Autres
Dépistage de médicaments

Marché de l\'immunohistochimie MEA - Par utilisateur final

Hôpitaux et laboratoires de diagnostic
Instituts de recherche
Autres

Marché de l\'immunohistochimie MEA - Par pays

EAU
Arabie Saoudite
Afrique du Sud
Reste de la MEA

Marché de l\'immunohistochimie MEA - Profils d\'entreprises

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Immunohistochemistry Market – By Product

1.3.2 MEA Immunohistochemistry Market – By Application

1.3.3 MEA Immunohistochemistry Market – By End User

1.3.4 MEA Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Incidences of Chronic and Infectious Diseases

5.1.2 Escalating R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Issues Related to Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Growing Opportunities in Emerging Countries

5.4 Future Trends

5.4.1 Rising Acceptance of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – MEA Analysis

6.1 MEA Immunohistochemistry Market Revenue Forecast and Analysis

7. MEA Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 MEA Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. MEA Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. MEA Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 MEA Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. MEA Immunohistochemistry Market – Country Analysis

10.1 MEA Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 UAE Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 UAE Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.1.3 UAE Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.3.1 UAE Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.1.4 UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Saudi Arabia Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Saudi Arabia Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.2.3 Saudi Arabia Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.3.1 Saudi Arabia Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.2.4 Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.3 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 South Africa Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 South Africa Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.3.3 South Africa Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.3.1 South Africa Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.3.4 South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.4 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.2 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.4.2.1 Rest of MEA Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.4.2.2 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.4.2.3 Rest of MEA Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.4.3 Rest of MEA Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.4.3.1 Rest of MEA Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.4.4 Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on MEA Immunohistochemistry Market

11.1 MEA: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 F. HOFFMANN-LA ROCHE LTD.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 MERCK KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 PerkinElmer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Abcam plc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Agilent Technologies, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BIO-RAD LABORATORIES INC.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Danaher

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Bio SB

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. UAE Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. UAE Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. UAE Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. UAE Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 8. UAE Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Saudi Arabia Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Saudi Arabia Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Saudi Arabia Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. Saudi Arabia Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 15. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. South Africa Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. South Africa Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 20. South Africa Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. South Africa Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 22. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 24. Rest of MEA Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 25. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 26. Rest of MEA Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 27. Rest of MEA Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 28. Rest of MEA Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 29. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 30. Organic Developments Done By Companies

Table 31. Inorganic developments done by Companies

Table 32. Glossary of Terms

LIST OF FIGURES

Figure 1. MEA Immunohistochemistry Market Segmentation

Figure 2. MEA Immunohistochemistry Market Segmentation, By Country

Figure 3. MEA Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The UAE to Show Significant Growth During Forecast Period

Figure 6. MEA PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to MEA Immunohistochemistry Market

Figure 8. MEA Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. MEA Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. MEA Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. MEA Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. MEA Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. MEA Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. MEA Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. MEA Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. MEA Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. MEA Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. MEA Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. MEA Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. MEA Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. MEA Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. MEA Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. MEA Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. MEA Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. MEA Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. MEA Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. MEA Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. MEA Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. MEA Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. MEA Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. MEA Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. MEA Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. MEA Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. MEA Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. MEA Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. MEA Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. MEA Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. MEA Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. MEA Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. MEA Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. MEA Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. MEA Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)

Figure 43. MEA Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. UAE Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Saudi Arabia Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. South Africa Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Rest of MEA Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 48. Impact of COVID-19 Pandemic in MEA Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample